Long-Term Survival and Value of (18)F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with (177)Lu-DOTATATE

Peptide receptor radionuclide therapy (PRRT) has been recognized as a promising therapy against neuroendocrine tumors (NETs). The use of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET) in NETs has been a matter of controversy. The purpose of this study was to evaluate the lon...

Full description

Saved in:
Bibliographic Details
Published in:Life (Basel)
Main Authors: Rodrigues, Margarida, Winkler, Kevin-Klaus, Svirydenka, Hanna, Nilica, Bernhard, Uprimny, Christian, Virgolini, Irene
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8000415/
https://ncbi.nlm.nih.gov/pubmed/33806393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11030198
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items